TSW
FURX

Thompson Siegel & Walmsley’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Thompson Siegel & Walmsley’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-364,463
Closed -$31.7M – 712
2014
Q1 		$31.7M Sell
364,463
-236,152
-39% -$18.2M 0.71% 24
2013
Q4 		$25.2M Buy
600,615
+49,009
+9% +$2.02M 0.59% 43
2013
Q3 		$24.3M Buy
551,606
+177,029
+47% +$7.33M 0.53% 60
2013
Q2 		$12.8M Buy
+374,577
New +$13.1M 0.28% 156

Other funds holding FURX

D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Thompson Siegel & Walmsley's FURX Position: Q2 2014 in Review

Thompson Siegel & Walmsley sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q2 2014, closing a stake of 364,463 shares — an estimated $31.7M sold.

Thompson Siegel & Walmsley first reported a position in FURX in Q2 2013 and held it in 4 quarters. The position peaked at $31.7M in Q1 2014. 102 funds tracked by Wall St. Rank hold FURX as of Q2 2014.

  • Thompson Siegel & Walmsley reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 364,463 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2014, an estimated $31.7M.
  • Thompson Siegel & Walmsley first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • Thompson Siegel & Walmsley's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $31.7M in Q1 2014.
  • 102 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2014.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2014, filed 12 Aug 2014.